Search
for

    Research 10 of 1000+

    1. Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection European Journal of Gastroenterology & Hepatology · 2007 · 41 citations
    2. Reversible Alopecia Universalis During Treatment with PEG-Interferon and Ribavirin for Chronic Hepatitis C Journal of Chemotherapy · 2005 · 27 citations
    3. Follow‐up of Adverse Drug Reactions from Peginterferon alfa‐2b—Ribavirin Therapy Pharmacotherapy · 2004 · 32 citations
    4. The efficacy and particular side effects of therapy peginterferon alpha-2a acute hepatitis C hemodialysed patients International Journal of Infectious Diseases · 2016
    5. Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin Dermatology · 2014 · 15 citations
    6. Cutaneous necrosis after injection of polyethylene glycol–modified interferon alfa Journal of The American Academy of Dermatology · 2005 · 26 citations
    7. Alopecia universalis following interferon alfa-2b and ribavirin treatment for hepatitis C. PubMed · 2007 · 4 citations
    8. Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy Hepatitis Monthly · 2015 · 2 citations
    9. Clinical Characteristics and Factors Associated with Hair Loss Severity in Chronic Hepatitis B Patients Receiving Pegylated Interferon-Alpha: A Retrospective Cohort Study Clinical Cosmetic and Investigational Dermatology · 2026
    10. Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege European Journal of Dermatology · 2014 · 10 citations
    All research results →

    Learn 3

    1. PEG-12 Dimethicone
    2. PEG-120 Methyl Glucose Dioleate
    3. PEG-40 Hydrogenated Castor Oil

    Community

    — no results

    Try a deeper search in community →